Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Neuroimaging and cognition using functional near infrared spectroscopy (fNIRS) in multiple sclerosis.
Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Helicobacter pylori Infection in Neuromyelitis Optica and Multiple Sclerosis.
Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
Early accurate diagnosis crucial in multiple sclerosis.
Pooling real-world multiple sclerosis patient data on a European level: a true story of success.
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
A case of Guillain-Barré syndrome with meningeal irritation.
Lateral ventricular cerebrospinal fluid diffusivity as a potential neuroimaging marker of brain temperature in multiple sclerosis: a hypothesis and implications.
Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study.
Post trauma vision syndrome and visual midline shift syndrome.
Evidence for classic complement activity in neuromyelitis optica.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis.
The impact of osteopontin gene variations on multiple sclerosis development and progression.
Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: A case control study.
Atomic view of a toxic amyloid small oligomer.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Pages
« first
‹ previous
…
285
286
287
288
289
290
291
292
293
…
next ›
last »